Cargando…

Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease

Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matoba, Keiichiro, Takeda, Yusuke, Nagai, Yosuke, Kawanami, Daiji, Utsunomiya, Kazunori, Nishimura, Rimei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678414/ https://www.ncbi.nlm.nih.gov/pubmed/31295940 http://dx.doi.org/10.3390/ijms20143393

Ejemplares similares

ROCK Inhibition May Stop Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
por: Kawanami, Daiji, et al.
Publicado: (2017)

Endothelial Dysfunction in Diabetes
por: Takeda, Yusuke, et al.
Publicado: (2020)

ROCK2-induced metabolic rewiring in diabetic podocytopathy
por: Matoba, Keiichiro, et al.
Publicado: (2022)

Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes
por: Matoba, Keiichiro, et al.
Publicado: (2021)

Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy
por: Matoba, Keiichiro, et al.
Publicado: (2017)

Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
por: Kawanami, Daiji, et al.
Publicado: (2016)

ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells
por: Takeda, Yusuke, et al.
Publicado: (2019)

SUN-522 A Case of Diabetic Ketoacidosis Associated with Thyroid Storm
por: Watanabe, Yui, et al.
Publicado: (2020)

The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders
por: Takashi, Yuichi, et al.
Publicado: (2022)

Significance of Metformin Use in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2020)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
por: Kawanami, Daiji, et al.
Publicado: (2020)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2018)

Unexpected Acute Hyperglycemia Following Pre-Surgical Discontinuation of SGLT2 Inhibitors in a Type 1 Diabetic Patient
por: Tsujimoto, Yuki, et al.
Publicado: (2023)

Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus
por: Nakashima, Akio, et al.
Publicado: (2018)

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study
por: Ando, Kiyotaka, et al.
Publicado: (2013)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study
por: Onda, Yoshiko, et al.
Publicado: (2016)

Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 5
por: Shikata, Kenichi, et al.
Publicado: (2019)

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2017)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Successful control of a case of severe insulin allergy with liraglutide
por: Kawanami, Daiji, et al.
Publicado: (2013)

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
por: Sakamoto, Masaya, et al.
Publicado: (2012)

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal–bolus insulin therapy: An open label, prospective, multicenter trial in Japan
por: Ogawa, Wataru, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure
por: Miyashita, Yumi, et al.
Publicado: (2008)

Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2022)

Role of Inflammation in the Pathogenesis of Diabetic Retinopathy
por: El-Asrar, Ahmed M. Abu
Publicado: (2012)

Is it possible to predict the onset of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes receiving insulin degludec? Potential role of previous day and next morning glucose values
por: Takahashi, Hiroshi, et al.
Publicado: (2020)

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy
por: Ristikj-Stomnaroska, Daniela, et al.
Publicado: (2019)

The role of inflammation in diabetic kidney disease
por: Jung, Su Woong, et al.
Publicado: (2021)

HDV Pathogenesis: Unravelling Ariadne’s Thread
por: Tseligka, Eirini D., et al.
Publicado: (2021)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j03o45vi659v6dqdm80tr0k6e9